CANSINOBIO Trademark

Trademark Overview


On Friday, August 19, 2022, a trademark application was filed for CANSINOBIO with the United States Patent and Trademark Office. The USPTO has given the CANSINOBIO trademark a serial number of 79358810. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by CANSINO BIOLOGICS INC.. The CANSINOBIO trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, oncological diseases, cardiovascular and cerebrovascular diseases, influenza, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; biological preparations for medical purposes for the treatment of cancer; pharmaceutical preparations, namely, anti-inflammatory preparations; analgesic preparations; anaesthetics and anti-infectives; vaccines; dietetic foods adapted for medical purposes; depuratives for the body; medical health care preparations, namely, health food supplements, dietary supplements for urinary health, vitamin preparations; sanitizing wipes; wadding for medical purposes; disinfectants
cansinobio

General Information


Serial Number79358810
Word MarkCANSINOBIO
Filing DateFriday, August 19, 2022
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7256904
Registration DateTuesday, January 2, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


Description of MarkThe mark consists of a stylized design of a DNA helix to the left of the wording "CanSinoBIO".
Goods and ServicesMedicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, oncological diseases, cardiovascular and cerebrovascular diseases, influenza, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; biological preparations for medical purposes for the treatment of cancer; pharmaceutical preparations, namely, anti-inflammatory preparations; analgesic preparations; anaesthetics and anti-infectives; vaccines; dietetic foods adapted for medical purposes; depuratives for the body; medical health care preparations, namely, health food supplements, dietary supplements for urinary health, vitamin preparations; sanitizing wipes; wadding for medical purposes; disinfectants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCANSINO BIOLOGICS INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameCANSINO BIOLOGICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameCANSINO BIOLOGICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Friday, April 5, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 5, 2024FINAL DISPOSITION PROCESSED
Tuesday, April 2, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 17, 2023NOTIFICATION PROCESSED BY IB
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 27, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 29, 2023REFUSAL PROCESSED BY IB
Friday, August 4, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 4, 2023REFUSAL PROCESSED BY MPU
Wednesday, June 28, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 27, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 7, 2023ASSIGNED TO EXAMINER
Saturday, January 7, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, January 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 29, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB